Concurrent treatment of chronic lymphocytic leukemia and acquired von Willebrand syndrome using a Bruton tyrosine kinase inhibitor: a case report.

Papa A, Biglietto M, Baldacci E, Mormile R, Corbingi A, Chistolini A, Santoro C, Romeo AA

Open source

DOI
10.2450/bloodtransfus.1440
Published
2026 Oct 21
Container
Blood transfusion = Trasfusione del sangue
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2450/bloodtransfus.1440,
  title = {Concurrent treatment of chronic lymphocytic leukemia and acquired von Willebrand syndrome using a Bruton tyrosine kinase inhibitor: a case report.},
  author = {Papa A and Biglietto M and Baldacci E and Mormile R and Corbingi A and Chistolini A and Santoro C and Romeo AA},
  year = {2026},
  journal = {Blood transfusion = Trasfusione del sangue},
  doi = {10.2450/bloodtransfus.1440},
  url = {https://doi.org/10.2450/bloodtransfus.1440}
}

RIS

TY  - JOUR
TI  - Concurrent treatment of chronic lymphocytic leukemia and acquired von Willebrand syndrome using a Bruton tyrosine kinase inhibitor: a case report.
AU  - Papa A
AU  - Biglietto M
AU  - Baldacci E
AU  - Mormile R
AU  - Corbingi A
AU  - Chistolini A
AU  - Santoro C
AU  - Romeo AA
PY  - 2026
JO  - Blood transfusion = Trasfusione del sangue
DO  - 10.2450/bloodtransfus.1440
UR  - https://doi.org/10.2450/bloodtransfus.1440
ER  - 

APA

A, P., M, B., E, B., R, M., A, C., A, C., C, S., & AA, R. (2026). Concurrent treatment of chronic lymphocytic leukemia and acquired von Willebrand syndrome using a Bruton tyrosine kinase inhibitor: a case report.. Blood transfusion = Trasfusione del sangue. https://doi.org/10.2450/bloodtransfus.1440

Source records